Related Experiment Video
Updated: Feb 22, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Knowledge-driven computational modeling in Alzheimer's disease research: Current state and future trends
Hugo Geerts1, Martin Hofmann-Apitius2, Thomas J Anastasio3
1In Silico Biosciences, Berwyn, PA, USA; Perelman School of Medicine, Univ. of Pennsylvania.
Advanced computational models can integrate complex data to understand Alzheimer's disease (AD) progression. Combining process algebras, data integration, and quantitative systems pharmacology offers new strategies for developing effective AD therapies.
Area of Science:
- Computational biology
- Systems biology
- Neuroscience
Background:
- Neurodegenerative diseases like Alzheimer's disease (AD) have complex, slowly progressing pathologies with significant presymptomatic phases.
- Omics studies and preclinical models have identified numerous potential AD-related processes, but integrating this information to understand causality is challenging.
- Traditional bioinformatics methods often provide correlations, hindering the development of a comprehensive view of AD pathogenesis.
Purpose of the Study:
- To review and propose a strategy for integrating complementary computational modeling approaches for Alzheimer's disease research.
- To highlight how advanced modeling can move beyond correlation to establish causality in AD pathology.
- To outline pathways for developing novel therapeutic interventions for AD.
Main Methods:
- Review of three computational approaches: Process Algebras (using Maude), Model-driven Integration of Data and Knowledge (OpenBEL platform), and Quantitative Systems Pharmacology (QSP).
- Focus on formalized domain expertise and quantitative, mechanism-driven modeling.
- Exploration of techniques like reverse causative reasoning and network jump analysis.
Main Results:
- Process algebras allow coarse-grained simulation and analysis of complex biological processes.
- Model-driven integration generates mechanistic knowledge and a disease taxonomy.
- Quantitative Systems Pharmacology provides fine-grained, predictive humanized computer models.
- A strategy is proposed to combine these methods for actionable insights.
Conclusions:
- Integrating diverse computational approaches offers a powerful methodology for understanding Alzheimer's disease.
- This integrated strategy can generate actionable knowledge for rational drug development and therapeutic interventions.
- Advanced computational modeling is crucial for future progress in treating and understanding AD.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....